These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38772048)

  • 21. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
    Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
    Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation.
    Singh G; Singh R; Monga V; Mehan S
    Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting
    Gohar NA; Fayed EA; A Ammar Y; A Abu Ali O; Ragab A; Mahfoz AM; Abusaif MS
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2367128. PubMed ID: 38913598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trifluoromethylated Flavonoid-Based Isoxazoles as Antidiabetic and Anti-Obesity Agents: Synthesis, In Vitro
    Algethami FK; Saidi I; Abdelhamid HN; Elamin MR; Abdulkhair BY; Chrouda A; Ben Jannet H
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
    Trinh BTD; Staerk D; Jäger AK
    J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and evaluation of novel l-phenylglycine derivatives as potential PPARγ lead compounds.
    Liu J; Su X; Li H; Fan L; Li Y; Tang X; Yan J; Chen X; Chen F; Liu J; Yang D
    Bioorg Med Chem; 2018 Aug; 26(14):4153-4167. PubMed ID: 30001846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
    Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
    Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facile synthesis and
    Punia R; Mor S; Khatri M; Kumar D; Das PP; Jindal DK; Kumar A; Selvaraj P; Kumar R; Mohil R; Jakhar K
    Future Med Chem; 2024; 16(10):999-1027. PubMed ID: 38910576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
    Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents.
    Acar Çevik U; Celik I; Paşayeva L; Fatullayev H; Bostancı HE; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200663. PubMed ID: 36760015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
    Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
    Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological activities, and molecular docking studies of triazolo[4,3-b]triazine derivatives as a novel class of α-glucosidase and α-amylase inhibitors.
    Seyfi S; Salarinejad S; Moghimi S; Toolabi M; Sadeghian N; Tüzün B; Firoozpour L; Ketabforoosh SHME; Taslimi P; Foroumadi A
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300628. PubMed ID: 38501879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of epigallocatechin (EGC) analogs selective to inhibit α-amylase over α-glucosidases via the incorporation of caffeine acid and its derivatives.
    Chen W; Zhou C; Chen J; Wang M; Zhou F; Wang C; Zhang X; Zhou W
    Bioorg Chem; 2022 Feb; 119():105515. PubMed ID: 34896919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
    Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
    Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.